ctrl K

Price Alert

Neuphoria Therapeutics In... (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

7.29

-0.35 (-4.59%)

At close: Aug 20, 2025, 9:40 AM

Neuphoria Therapeutics Income Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Revenue	15M	662.72K	n/a	n/a	n/a	n/a
Cost of Revenue	165.43K	n/a	165.71K	165.7K	n/a	n/a
Gross Profit	14.84M	662.72K	-165.71K	-165.7K	n/a	n/a
Operating Income	11.98M	-3.7M	-3.57M	-2.39M	-4.55M	-5.47M
Interest Income	12.74K	30.61K	36.1K	52.62K	54.72K	86.44K
Pretax Income	11.18M	-1.93M	-937K	-2.76M	-4.59M	-5.51M
Net Income	11.26M	-1.94M	-805K	-2.78M	-4.55M	-5.47M
Selling & General & Admin	1.24M	2.63M	1.67M	1.03M	2.52M	2.38M
Research & Development	1.62M	1.74M	1.9M	1.2M	2.03M	3.09M
Other Expenses	n/a	n/a	n/a	-1K	n/a	n/a
Operating Expenses	2.86M	4.37M	3.57M	2.23M	4.55M	5.47M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.02M	4.37M	3.57M	2.39M	4.55M	5.47M
Income Tax Expense	-81.19K	11.61K	-132K	16.38K	-34.79K	-34.79K
Shares Outstanding (Basic)	234.01M	234.01M	234.01M	143.52M	137.23M	124.67M
Shares Outstanding (Diluted)	234.01M	234.01M	234.01M	143.52M	137.23M	124.67M
EPS (Basic)	0.05	-0.01	-0.00	-0.02	-0.03	-0.04
EPS (Diluted)	0.05	-0.01	-0.00	-0.02	-0.03	-0.04
EBITDA	11.35M	-3.23M	-771K	-2.6M	-4.29M	-5.3M
EBIT	11.18M	-3.4M	-937K	-2.76M	-4.46M	-5.47M
Depreciation & Amortization	165.43K	166.12K	165.71K	165.7K	165.69K	165.91K